17 Recruiting Studies Using Ipatasertib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ipatasertib
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor
📍 Southern Highlands Cancer Centre — Bowral, New South Wales
Breast Cancer
View Study & Checklist ➔Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
📍 Banner University Medical Center - Tucson — Tucson, Arizona
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
View Study & Checklist ➔Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
📍 UCSF Medical Center-Mission Bay — San Francisco, California
Fallopian Tube Endometrioid Adenocarcinoma
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Lymphoma
View Study & Checklist ➔Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
📍 ECOG-ACRIN Cancer Research Group — Philadelphia, Pennsylvania
Advanced Lymphoma
View Study & Checklist ➔Prostate Cancer Biomarker Enrichment and Treatment Selection
📍 Cross Cancer Institute — Edmonton, Alberta
Prostate Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
📍 UCSF Helen Diller Family CCC — San Francisco, California
Ovarian Cancer
View Study & Checklist ➔Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
📍 Western Regional Medical Center at Cancer Treatment Centers of America — Goodyear, Arizona
Solid Tumors
View Study & Checklist ➔Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Locally Advanced Malignant Solid Neoplasm
View Study & Checklist ➔AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Endometrial Cancer
View Study & Checklist ➔Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
📍 Moffitt Cancer Center — Tampa, Florida
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
📍 GHdC Site Les Viviers — Charleroi,
Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
📍 City of Hope — Duarte, California
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
📍 City of Hope — Duarte, California
Metastatic Breast Cancer
View Study & Checklist ➔